Clinical trial
Effects and Mechanism of Adipokines Cardiac Protection in Obese Patients With Coronary Artery Disease (CAD)
NCT04570527 is registered in ClinicalTrials.gov with Xijing Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects and Mechanism of Adipokines Cardiac Protection in Obese Patients With Coronary Artery Disease (CAD)
- Lead sponsor
- Xijing Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- January 1, 2019
- Completion date
- December 30, 2022
- Enrollment
- 200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
adiposis; heart, coronary artery disease (cad) (e.g., angina, myocardial infarction, and atherosclerotic heart disease (ashd)), obesity